RE: Products might be on the shelves already "Development work on the first products will begin immediately."
----------------------------------------------------------------------------------------------------------------------------------------
When I spoke to them a few days ago I asked about a timeline for products hitting the shelves and was told that there would be news out in the future covering the progress of this developing product line. But what has me intrigued (FWthat'sW) is the following portions of the NR from Feb. 02,2012
-----------------------------------------------------------------------------------------------------------------------------------------
"Today's announcement is part of a larger strategic plan for SemBioSys and Tasly to collaborate on a number of fronts," said James Szarko, President and CEO of SemBioSys. "With this long approval process now completed we will rapidly develop and commercialize a number of exciting new products into Tasly's well established distribution channels," he concluded.
The new Company is structured as a Sino-Foreign Equity Joint Venture (the "Joint Venture"), and will develop and commercialize products for China and the world. Development work on the first products and product programs is already under way. Select products and programs that are under evaluation or under development with a range of timelines are listed below:"
-----------------------------------------------------------------------------------------------------------------------------------------
"The new company........". Hmmm. The new company that could eventually be spun off with a name change and it's own TSX listing a few years down the road ????
Finally, the portion below and all you BioExx fans out there ( I was once too) take careful note.
-----------------------------------------------------------------------------------------------------------------------------------------
Near Term
Research and develop a new generation of Modern traditional Chinese medicine (TCM) products utilizing oilbodies to develop and further enhance TCM products. The total international TCM market is estimated to be US$20 billion and Tasly's revenues are approximately US$1 billion growing at in excess of 20% per annum.
*********************Develop a line of functional food and beverages based on oilbodies that result from SemBioSys' patented oil seed processing platform. The oil and proteins are produced in a continuous cold system that does not denature the oil and proteins, resulting in higher quality products with greater market value than those currently produced using standard heat and hexane extraction methods. The global functional food and beverage market is estimated to exceed US$130 billion by 2015.***********
************Tasly recently entered this exciting new market and believes its current distribution provides huge upside growth potential in China based on the results of its initial products.*************************